Please Wait

Applying Filters...

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

methyl 4 hydroxybenzoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 DKSH, 1 Pharm-RX Chemical, 1 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 2 Nanjing Well Pharmaceutical, 2 Actylis, 10 BASF, 1 Finar, 1 Gangwal Chemicals, 1 Kerry, 1 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

8 Solubilizers, 8 Parenteral, 7 Topical, 7 Fillers, Diluents & Binders, 5 Granulation, 5 Thickeners and Stabilizers, 4 Controlled & Modified Release, 4 Film Formers & Plasticizers, 3 Direct Compression, 2 Rheology Modifiers, 2 Coating Systems & Additives, 1 Emulsifying Agents, 1 Disintegrants & Superdisintegrants, 1 API Stability Enhancers